Multimodality therapy in penile cancer: when and which treatments?

Por Pagliaro, Lance C., Crook, Juanita
Publicado em 2008

Challenges in the long-term management of patients with metastatic renal cell carcinoma treated with targeted therapy: Optimizing surgery, systemic therapy and quality of life

Por Jonasch, Eric, Pagliaro, Lance C., Tannir, Nizar M.
Publicado em 2010

Ischemic Optic Neuropathy Associated with Low Dose Interferon Alfa: Report of Two Cases

Por Rodney, Alan J., Gombos, Dan S., Pagliaro, Lance C., Tannir, Nizar M.
Publicado em 2009

Epidermal Growth Factor Receptor–Targeted Therapy in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Penis

Por Carthon, Bradley C., Ng, Chaan S., Pettaway, Curtis A., Pagliaro, Lance C.
Publicado no BJU Int (2014)

Invasive extramammary Paget's disease of the bladder diagnosed 18 years after noninvasive extramammary Paget's disease of the vulva

Por Onaiwu, Cherry O., Ramirez, Pedro T., Kamat, Ashish, Pagliaro, Lance C., Euscher, Elizabeth E., Schmeler, Kathleen M.
Publicado em 2014

Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists()

Por Dayyani, Farshid, Pettaway, Curtis A., Kamat, Ashish M., Munsell, Mark F., Sircar, Kanishka, Pagliaro, Lance C.
Publicado em 2012

Penile cancer with visceral metastasis and p16/human papillomavirus positivity: An unusual case of long-term survival

Por Mehra, Nandini S., Ho, Thanh P., Herrera Hernandez, Loren, Quevedo, J. Fernando, Costello, Brian A., Pagliaro, Lance C.
Publicado no Urol Case Rep (2020)

Front-line Treatment with Gemcitabine, Paclitaxel and Doxorubicin for Patients with Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase...

Por Siefker-Radtke, Arlene O., Campbell, Matthew T., Munsell, Mark F., Harris, Deborah R., Carolla, Robert L., Pagliaro, Lance C.
Publicado no Urology (2015)

Phase II Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal Cell Carcinoma

Por Maiti, Abhishek, Nemati-Shafaee, Maryam, Msaouel, Pavlos, Pagliaro, Lance C., Jonasch, Eric, Tannir, Nizar M., Shah, Amishi Y.
Publicado no Clin Genitourin Cancer (2017)

Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer

Por Millikan, Randall E., Wen, Sijin, Pagliaro, Lance C., Brown, Melissa A., Moomey, Brenda, Do, Kim-Anh, Logothetis, Christopher J.
Publicado em 2008

Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine, and bevacizumab at a tertiary cancer center

Por Jonasch, Eric, Lal, Lincy S., Atkinson, Bradley J., Byfield, Stacey DaCosta, Miller, Lesley Ann, Pagliaro, Lance C., Feng, Chun, Tannir, Nizar M.
Publicado no BJU Int (2010)

Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study

Por Pagliaro, Lance C., Williams, Dallas L., Daliani, Danai, Williams, Michael B., Osai, William, Kincaid, Michael, Wen, Sijin, Thall, Peter F., Pettaway, Curtis A.
Publicado em 2010

Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II t...

Por Subbiah, Vivek, Meric-Bernstam, Funda, Mills, Gordon B, Shaw, Kenna R Mills, Bailey, Ann Marie, Rao, Priya, Ward, John F, Pagliaro, Lance C
Publicado no J Hematol Oncol (2014)

Persistent, Biologically Meaningful Prostate Cancer After 1 Year of Androgen Ablation and Docetaxel Treatment

Por Tzelepi, Vassiliki, Efstathiou, Eleni, Wen, Sijin, Troncoso, Patricia, Karlou, Maria, Pettaway, Curtis A., Pisters, Louis L., Hoang, Anh, Logothetis, Christopher J., Pagliaro, Lance C.
Publicado em 2011

Phase II trial of Pemetrexed plus Gemcitabine in patients with advanced non-clear cell renal cell carcinoma

Por Richey, Stephen L, Tamboli, Pheroze, Ng, Chaan S, Lin, E, Lim, Zita D, Araujo, John C, Jonasch, Eric, Sharma, Padmanee, Pagliaro, Lance C, Tannir, Nizar M
Publicado em 2013

Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience

Por Rodney, Alan J., Tannir, Nizar M., Siefker-Radtke, Arlene O., Liu, Ping, Walsh, Garrett L., Millikan, Randall E., Swisher, Stephen G., Tu, Shi-Ming, Pagliaro, Lance C.
Publicado em 2010

Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer

Por Zurita, Amado J., Pisters, Louis L., Wang, Xuemei, Troncoso, Patricia, Dieringer, Pauline, Ward, John F., Davis, John W., Pettaway, Curtis A., Logothetis, Christopher J., Pagliaro, Lance C.
Publicado no Prostate Cancer Prostatic Dis (2015)

Upfront, Randomized, Phase 2 Trial of Sorafenib Versus Sorafenib and Low-Dose Interferon Alfa in Patients With Advanced Renal Cell Carcinoma: Clinical and Biomarker Analysis

Por Jonasch, Eric, Corn, Paul, Pagliaro, Lance C., Warneke, Carla L., Johnson, Marcella M., Tamboli, Pheroze, Ng, Chaan, Aparicio, Ana, Ashe, Robynne G., Wright, John J., Tannir, Nizar M.
Publicado no Cancer (2010)

Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review...

Por Yang, Fang, Markovic, Svetomir N., Molina, Julian R., Halfdanarson, Thorvardur R., Pagliaro, Lance C., Chintakuntlawar, Ashish V., Li, Rutian, Wei, Jia, Wang, Lifeng, Liu, Baorui, Nowakowski, Grzegorz S., Wang, Michael L., Wang, Yucai
Publicado no JAMA Netw Open (2020)

Phase I Study of Ixabepilone, Mitoxantrone, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy: A Study...

Por Rosenberg, Jonathan E., Ryan, Charles J., Weinberg, Vivian K., Smith, David C., Hussain, Maha, Beer, Tomasz M., Ryan, Christopher W., Mathew, Paul, Pagliaro, Lance C., Harzstark, Andrea L., Sharib, Jeremy, Small, Eric J.
Publicado em 2009